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Background: Our experience with a left internal thoracic artery graft to the
left anterior descending artery via a left anterior small thoracotomy is
reviewed to evaluate midterm results. Methods: From November 1994 to
April 1997, four hundred sixty patients were scheduled to undergo a left
internal thoracic artery graft to the left anterior descending coronary artery
via a left anterior small thoracotomy; 26 of these patients (5.7%) were
converted and 434 of them had the operation. Two hundred fourteen
patients (49.3%) had isolated disease of the left anterior descending artery,
and 220 patients(50.7%) had multiple vessel disease. A sufficient length of
the left internal thoracic artery was harvested to reach the left anterior
descending artery. Results: Three hundred nine patients (71.2%) underwent
extubation by hour 2. Mean intensive care unit stay was 4.2 6 4.5 hours;
mean postoperative hospital stay was 66 6 29 hours; the 30-day mortality
rate was 1.1%; the late mortality rate was 1.4%. Eighteen patients under-
went reoperation early (<230 days), and eight patients underwent reopera-
tion late (>30 days) because of conduit/anastomotic malfunction. Four
patients underwent reoperation with patent anastomosis for progression of
disease (n 5 3) or pericarditis (n 5 1). Three patients had a percutaneous
transluminal coronary angioplasty. Cumulating angiographic and stress
Doppler flow assessment results, a patent anastomosis was obtained in 417
patients and a nonrestrictive anastomosis in 404 patients. Twenty-nine
months after surgery, survival was 97.1% 6 0.7% (95% confidence interval
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90.5% to 100%) and event-free survival 89.4% 6 1.2% (95% confidence
interval 78.2% to 100%). In the last 190 patients, with our increased
experience and better instruments, we obtained a patent anastomosis in 188
patients (98.9%) and a nonrestrictive anastomosis in 185 (97.4%). Conclu-
sions: Left anterior small thoracotomy gives acceptable midterm results.
Incidence of patent and nonrestrictive anastomoses was satisfactory,
especially in the most recent part of our experience, when the learning
curve ended. (J Thorac Cardiovasc Surg 1998;115:763-71)
Left anterior descending (LAD) artery graftingwith the left internal thoracic artery (LITA) via
a left anterior thoracotomy was introduced by
Vassili Kolessov in the 1960s.1 More recently,
other authors, such as Benetti and Ballester,2
Acuff and associates,3 Robinson and associates,4
and Subramanian and Stelzer,5 reproposed the
same operation with only a few modifications. The
possibility of grafting the most important coro-
nary artery, using the most important arterial
conduit,6 generated a great deal of interest, even
if some concern still exists about some technical
aspects and if midterm results are not yet well
known.
Our experience began in November 1994. We
report our results with LITA to LAD grafting via a
left anterior small thoracotomy (LAST) on a beating
heart.
Patients and methods
From November 21, 1994, to April 20, 1997, 460
patients were scheduled for LITA to LAD grafting via a
LAST on a beating heart; in 26 of them (5.7%) the
operation could not be accomplished, and a median
sternotomy was performed. The preoperative data of the
434 patients who underwent the procedure are shown in
Table I.
Surgical indications. Candidates for the LAST oper-
ation are patients with a LAD disease where (1) a
(stent) percutaneous transluminal coronary angioplasty
(PTCA) is not feasible because of technical aspects, (2)
the surgical procedure is chosen by the cardiologist or
the patient himself, or (3) a restenosis after a (stent)
PTCA occurs.
Patients with multiple-vessel disease can undergo the
LAST operation in selected cases. Assuming that the
LAD lesion is suitable for surgery, the other coronary
vessels must be (1) occluded and refilled by collateral
circulation, (2) related to previously infarcted areas, (3)
not graftable because of technical aspects (for example,
distal stenoses with small coronary size, heavy calcifica-
tions), and (4) suitable for an integrated approach.7 This
group of patients is a very select group and needs only a
single LAD graft. Therefore we are not proposing to
perform a single LAD graft in multiple-vessel disease.
Where the cardiopulmonary bypass is itself the cause of
high postoperative morbidity because of concomitant risk
factors (Table I), patients can benefit from LITA to LAD
grafting on a beating heart as a palliative operation.
Anatomic contraindications. The site for anastomosis
is below the second diagonal branch; therefore our atten-
tion has to be addressed to this portion of the LAD. An
intramyocardial, calcified, small-sized (, 1.5 mm) LAD
should be avoided, when these anatomic aspects can be
recognized before surgery at angiography. Sometimes the
heart is rotated to the right; in this situation the position
of the LAD becomes substernal and the anastomosis is
impossible to do. Unfortunately, these patients could not
be identified before the operation, even with increasing
experience.
Anesthetic management. Anesthesia is induced with
fentanyl and sodium thiopental and is maintained with
fentanyl and droperidol. Muscular relaxation was ob-
tained with pancuronium bromide. A Carlens tube was
used in the beginning of our experience to avoid left lung
ventilation if necessary, but its use is now discontinued. At
the beginning of the procedure, a continuous infusion of
diltiazem (10 mg/hr) is begun; small boluses (10 mg) are
injected, when necessary, to obtain a heart rate of 45 to 50
beats/min. In the final part of the operation a mixture of
nitrous oxide and oxygen is used, to allow a rapid awak-
ening of the patient.
Surgical technique. The patient is positioned on the
operating table in the supine position as usual. The chest
is opened via a LAST in the fourth or fifth intercostal
space, according to the angiographic anatomy; the pleural
cavity is always opened. The ribs are retracted. No costal
cartilage is resected; however, sometimes the condroster-
nal joint breaks by itself: it will be reconstructed during
the wound closure. The pericardium is opened to assess
the feasibility of the procedure. The LITA is then identi-
fied and dissected. In the first part of our experience,8 we
harvested a short segment of the LITA. More recently,
with increasing experience and new instruments, if neces-
sary, a much longer segment can be harvested. The
conduit is harvested distally up to the bifurcation and
proximally for the length necessary to reach the LAD. For
this purpose, in the last 190 cases, we used a new
retractor9 (Cardio Thoracic System, Cupertino, Calif.)
that pulls up the chest wall and exposes the LITA very
clearly; the conduit can be easily dissected, skeletonized,
or pedicled up to the first rib, if necessary. Heparin (1
mg/kg) is given, and the distal LITA is ligated and
transected. Five milliliters of a solution with papaverine (1
mg/ml) is injected into the distal tip, which is then clipped.
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A second retractor, to be used for the distal anastomosis,
is then positioned. The LAD is occluded proximally and
distally with a 4-0 polypropylene (Prolene; Ethicon, Inc.,
Somerville, N.J.) suture with a 25 mm needle, passed
deeply to surround the vessel. To avoid any direct com-
pression of the suture on the coronary wall,8 both needles
are passed through a small piece of silicone tubing. Both
4-0 sutures are gently snared to ensure an operative field
as bloodless as possible. A stabilizer with two feet (Cardio
Thoracic System) connected to the retractor is positioned
parallel to the LAD and pushed down gently. The up and
down movement of the heart is stabilized; as a conse-
quence, the LAD remains steady and its movements are
nearly abolished. In no case is preconditioning of the
distal LAD territory performed. The distal LITA is pre-
pared in the usual manner; the LAD is dissected and
incised. The anastomosis is performed with two 8-0 Pro-
lene sutures with 6 mm needles.8 Both of them are passed
three times at the heel and at the apex; the LITA is then
pulled down to reach the LAD. The two edges of the
vessels now face each other, and the anastomosis is
completed with two running sutures from both sides. The
LITA and the LAD are then unclamped and the hemo-
stasis is checked. Heparin is reversed with protamine
(1/1); more recently, we have ceased to reverse heparin. A
drain is positioned in the chest together with a small
catheter to infuse an analgesic drug (bupuvicaine). The
wound is closed as usual.
Postoperative course. All patients were admitted to the
intensive care unit, where blood samples, a chest roent-
genogram, and an electrocardiogram were obtained. The
flow velocity pattern in the LITA was assessed by Doppler
echocardiography. Because the LITA remains partially in
its natural position, the flow pattern is easily detectable.
The increase of the diastolic component of the flow
velocity pattern is considered a demonstration of patency
of the anastomosis, even if nothing can be said about its
quality.
A few hours later, the patients were transferred to the
ward. The drain and the intrapleural catheter were re-
moved on the morning of postoperative day 1. A new
Doppler echocardiography flow velocity assessment is
then repeated, at rest and during the Azoulay maneuver,
as proposed by one of the authors (S.G.).16 If both of the
patient’s legs are lifted up, first passively, then leaving the
patient alone to perform an isometric exercise, acute
hypervolemia is induced, with an increase of the cardiac
output and heart rate. If the Doppler echocardiography
flow is recorded at rest and during the Azoulay maneuver,
an increase of the diastolic flow can be observed (Fig. 1).
Angiographic studies clearly show that this pattern is
characteristic of a nonrestrictive anastomosis (unpub-
lished data).
Fig. 1. A, The flow velocity pattern on the ungrafted
LITA shows a dominant systolic component. B, When the
LITA is anastomosed to the LAD, the diastolic flow
velocities increase and often become higher than the
systolic values (peak 25 vs 21 cm/sec, mean 18 vs 15
cm/sec). C, During the Azoulay maneuver, all the diastolic
velocities increase further (peak from 25 to 44 cm/sec,
mean from 18 to 30 cm/sec).
Table I. Preoperative data (434 patients)
Age (yr) 61.1 6 9.9 (mean, 32-88)
$70 yr 85 (19.6%)
Sex (female) 54 (12.4%)
Unstable angina 126 (29.0%)
Previous MI 130 (29.9%)
Major risk factors 85 (19.6%)
Age .75 yr 27 (6.2%)
Redo 14 (3.2%)
Diffuse encephalopathy 13 (3.0%)
Malignancy 13 (3.0%)
Renal failure 10 (2.3%)
Diffuse vasculopathy 4 (0.9%)
Untouchable aorta 3 (0.7%)
Coagulation disorders 2 (0.5%)
HIV positive 1 (0.2%)
Hepatic cirrhosis 1 (0.2%)
Single-LAD disease 214 (49.3%)
Multiple-vessel disease 220 (50.7%)
LM disease 17 (4.0%)
EF (%) 61.5 6 12.9 (15–90)
# 35 13 (3.0%)
MI, Myocardial infarction; LAD, left anterior descending; LM, left main;
EF, ejection fraction.
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Many patients had a postoperative angiogram, mainly
for study purposes. However, every patient in whom an
anastomotic malfunction was suspected had an angio-
gram. Thus patients were also, in part, selected for
arteriography.
In the morning of postoperative day 2, most of the
patients were discharged.
Follow-up. Follow-up for all patients was performed at
our outpatient clinic at the end of postoperative months 1
and 6; eighty-six of them had only a single visit because
they had not completed a 6-month postoperative period.
All patients performed a stress test and, if possible, a
myocardial scintiscan was obtained on the second visit.
LAD flow velocity evaluation at rest and during the
Azoulay maneuver was also repeated.
The follow-up was 100% complete; it ranged from 25
days to 29 months (mean 13.5 6 7.8).
Statistical analysis. Results are expressed as mean
value (standard deviation unless otherwise indicated).
Statistical analysis comparing the two groups was per-
formed with unpaired two-tailed t testing for the means or
x2 test for categoric variables. Survival and event-free
survival curves were obtained with the Kaplan-Meier
method (BMDP 1L software, Los Angeles, Calif.). The
statistical significance was calculated with the Mantel-Cox
test and z-test. When necessary the confidence intervals
(CIs) were added.
Results
In 26 patients (5.7%) the LAST operation was not
accomplished because the LAD was not visible (16
cases), was calcified (4 cases), was substernal (3
cases), or was too small (2 cases) or the LITA was
injured during the harvesting (1 case). All patients
had an uneventful operation via a median sternot-
omy.
Surgical details. The fourth intercostal space was
used in 181 patients (41.7%), the fifth in 234 pa-
tients (53.9%), and both in the remaining 19 pa-
tients (4.4%). In the first part of our experience, we
preferred to use the fifth intercostal space, but more
recently the choice is determined by the surgical
anatomy of the LAD, detectable at angiography
(that is, intramyocardial position, distal size). Both
intercostal spaces were opened in a few cases be-
cause of the necessity to find a suitable anastomotic
site.
Perioperative and postoperative data are shown
in Tables II and III.
Early and late deaths. During the first 30 days
after surgery, five patients (1.1%) died after a mean
of 6.8 6 7.5 days. Cause of death was cardiac, but
not operation related, in four patients (sudden
death from inferolateral myocardial infarction with
widely patent graft at necropsy; low output syn-
drome, present before surgery and not reversed by
the graft, widely patent at necropsy; cardiac tampon-
ade in a patient who had a successful stent PTCA on
the right coronary artery 3 days after the LAST
procedure; cardiac failure early after a stent PTCA
on the circumflex artery) and non-cardiac related
(massive intestinal infarction) in one patient.
After 30 days from surgery, six patients (1.4%)
died after a mean of 130 6 120 days from the
procedure. Cause of late death was cardiac in three
patients, operation related in one patient (multior-
gan failure in a patient who had simultaneous
carotid endoarterectomy, femorofemoral bypass,
and LAST operation; bleeding from a LITA collat-
eral caused hypotension; and renal failure, the pri-
mary cause of the problems), and not operation
related in two patients (both patients had myocar-
dial infarction in a previously not diseased circum-
flex artery, and both were receiving long-term dial-
ysis treatment; one of them had necropsy that
showed a widely patent anastomosis). In the last
three patients, the cause of death was not cardiac
Table II. Perioperative data
LAD occlusion time (min) 25.3 6 8.0
Anastomotic time (min) 18.3 6 5.8
Operation time (hr) 2.1 6 0.5
LAD grafting
LITA (%) 398 (91.7)
IEA
Elongation (%) 32 (7.4)
Bridge from LITA (%) 1 (0.2)
SVG elongation (%) 3 (0.7)
Diagonal grafting (IEA as Y graft) (%) 2 (0.5)
Associated surgery (%) 6 (1.4)
LAD, Left anterior descending; LITA, left internal thoracic artery; IEA,
interior epigastric artery; SVG, saphenous vein graft.
Table III. Postoperative data
N (percent of total)
Extubation
OR 141 (32.5)
ICU (first 2 hr) 168 (38.7)
Bleeding (ml/12 hr) 149 6 191
Redo for bleeding 6 (1.4)
Transfusions 10 (2.3)
Mean CK-MB peak (IU) 20 6 15
Mean ICU stay (hr) 4.2 6 4.5
Atrial fibrillation 35 (8.0)
Pericarditis 3 (0.7)
Postoperative in-hospital stay (hr) 66 6 29
Discharged by postoperative day 2 295 (8.0)
Delayed chest-wound healing 12 (2.8)
Late pulmonary hernia 2 (0.5)
OR, Operating room; ICU, Intensive care unit.
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(malignancy; cerebral hemorrhage; hepatic cirrho-
sis).
In total, of 11 patients who died, 10 had a patent
anastomosis, demonstrated by angiography (3 pa-
tients), Doppler flow velocity assessment during the
Azoulay maneuver (3 patients) or at rest only (1
patient), or necropsy (3 patients). The last patient
died late of hepatic cirrhosis after a successful
reoperation with cardiopulmonay bypass for graft
occlusion.
Further revascularization on the target coronary
vessel. Twenty-six patients (6.0%) had a redo for
anastomotic stenosis (10 patients) or graft occlusion
(16 patients) 18 patients (4.2%), during the first 30
days from surgery (mean 5.2 6 5.3); and 8 patients
(1.8%), after the first month (mean 138 6 111 days).
All patients underwent an uneventful reoperation,
via a median sternotomy in 25 patients and a
re-LAST in 1 patient, 24 patients with cardiopulmo-
nary bypass and 2 patients remaining off pump. As
previously reported, one patient died late of hepatic
cirrhosis.
The incidence of reoperation is decreasing with
time because experience is increasing and because
new instruments are now available. In the last 190
patients there were four reoperations, 2.1% (for
anastomotic stenosis in 2 patients and conduit oc-
clusion in 2 patient), with a p value , 0.001 versus
the remaining patients.
Three more patients (0.7%) needed catheter re-
vascularization. The first one had a successful pro-
tected infrastent PTCA of the LAD because of an
early anastomotic stenosis. At the routine angio-
graphic follow-up (4 months later), the anastomotic
stenosis disappeared. A second patient, with an
asymptomatic anastomotic stenosis detected after
an early routine angiogram, had a successful PTCA
of the anastomosis 126 days after surgery. An anas-
tomotic stenosis later developed in a third patient
after an early perfect result on angiographic follow-
up; it was successfully dilated 153 days after surgery.
Fig. 2. Angiograms performed 24 hours (A) and 23
months (B) after the procedure. The anastomosis is
unchanged, and no intimal hyperplasia is present at the
occlusion sites in the LAD.
Fig. 3. Angiograms performed 48 hours (A) and 38 days
(B) after the procedure. The severe stenosis, shown in A
and not visible in B, is likely due to a clot.
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Reoperations with patent conduit. Four patients
(0.9%) underwent reoperation with patent distal
anastomosis (1 to 119 days, mean 55.0 6 53.6 days),
two of them early (1 and 3 days, for inferior evolving
myocardial infarction caused by occlusion of a pre-
viously moderately diseased right coronary artery
and for unstable angina caused by subocclusion of a
previously mildly stenosed marginal branch) and
two of them late (97 and 119 days, the first one for
recurrent severe pericarditis and the second one for
a new LAD lesion, proximal to a distal patent
anastomosis, not related to the LAD occlusion
during the first procedure: the same LITA was used
for an intermediate anastomosis leaving the distal
portion intact).
Integrated approach. Eleven patients (2.5%) had
a scheduled postoperative (stent) PTCA on the
circumflex or right coronary arteries (three proce-
dures in other institutions). All procedures were
successful; unfortunately, for different reasons, two
patients died, as previously described.
Quality control of the anastomosis. All the pa-
tients had a Doppler echocardiography flow velocity
assessment at rest or during the Azoulay maneuver.
However, as in conventional surgery, the Doppler
flow assessment and the stress test can demonstrate
that the operation had a good result, but not the
anatomic details. In 271 patients (62.4%) a postop-
erative angiography was performed during the first
year after surgery. The anastomosis was patent in
254 cases (patency rate 93.7%) and patent without
any malfunction in 241 cases (perfect patency rate
88.9%). In total, after results were accumulating
from angiography and Doppler echocardiography, a
patent anastomosis was obtained in 417 patients
(96.1%) and a nonrestrictive anastomosis in 404
patients (93.1%).
Two groups of patients had postoperative angiog-
raphy: the first included patients who accepted
postoperative angiography only for scientific pur-
poses, provided that this could be obtained in rea-
sonable time; the second group included patients
where a suspicion of anastomotic or graft malfunc-
tion was present after a Doppler flow velocity eval-
uation. For this reason the real angiographic pa-
tency rate is potentially higher than the values
showed by us.
However, if we consider the last 190 patients,
angiographic results are improving. In this series,
134 angiographies were performed: 132 were patent
(patency rate 98.5%, CI 90.6% to 100%) and 129
showed no abnormality (perfect patency rate 96.3%,
CI 93.8% to 98.7%). The total patency rate (angiog-
raphy plus Doppler echocardiography) was 98.9%
(CI 92.1% to 100%) (188 of 190), and 185 patients
(97.4%) had a nonrestrictive anastomosis (CI 94.3%
to 100%) (185 of 190).
A favorable unexpected event occurred: six pa-
tients, who had anastomotic or graft malfunction at
Fig. 4. Survival (solid line) and event free survival (dotted
line) 29 months after the procedure.
Table IV. Preoperative and postoperative data
according to the extent of the coronary disease
Single-LAD
disease
(n 5 214)
Multiple-vessel
disease
(n 5 220) p Value
Age (yr) 59.7 6 9.6 62.4 6 9.9 0.004
.75 yr 10 17 .0.2
EF (%) 64.2 6 12.4 59.1 6 12.9 ,0.001
,35 4 9 0.144
Redo 3 11 0.075
Major risk factors 31 54 0.040
CK-MB peak (UI/L) 19.7 6 16.4 20.9 6 13.6 .0.2
ICU stay (hr) 4.1 6 4.5 4.3 6 4.8 .0.2
Postoperative hospital
stay (hr)
65 6 25 63 6 30 .0.2
Deaths 1 10 ,0.001
#30 Days — 5 0.081
.30 Days 1 5 .0.2
Anastomotic/conduit failure 10 19 0.175
surgical revision 9 17 .0.2
(stent)PTCA 1 2 .0.2
Alive, asymptomatic, with/
without medical treatment
213 210 .0.2
Alive, asymptomatic, without
redo/PTCA on LAD
203 192 .0.2
Survival (29 mo) 99.5 6 0.5 95.2 6 1.1 ,0.001
Event-free survival
(29 mo)
92.5 6 1.5 86.8 6 1.8 ,0.001
LAD, Left anterior descending artery; EF, ejection fraction; CK-MB,
creatine kinase MB; ICU, intensive care unit; PTCA, percutaneous trans-
luminal coronary angioplasty.
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follow-up angiography, showed reversal of the ab-
normality after an interval between the two angio-
grams of 94 6 56 days (Fig. 2). This was probably
due to small clots, which can disappear after a few
weeks, or to adventitial hematomas, which also can
reverse. It appears that no decision has to be made
early after surgery. If any angiographic abnormality
exists, a repeat angiogram is performed 2 to 3
months later. Because of this experience, we de-
cided not to reverse heparin at the end of the
procedure, hoping to limit clot formation; however,
at this time we have no data to support this hypoth-
esis, even though the hypothesis seems reasonable.
Twenty-seven patients underwent a repeat angio-
gram more than 1 year after surgery (mean 16.5 6 4.2
months), to evaluate the stability of the anastomosis
with time and to check the development of LAD
irregularities or stenosis in the proximal and distal
occlusion sites. No patient showed any changes in
shape of the anastomosis or of the LAD (Fig. 3).
Clinical results. At a mean follow-up of 13.5 6
7.8 months, 423 patients (97.5%) are alive and
asymptomatic with or without medical treatment
with negative stress tests in every case; 395 patients
(91.0%) are alive, asymptomatic, and without a
repeated surgical or cardiologic intervention on the
LAD. Actuarial survival and event-free survival are
shown in the Fig. 4. For the purpose of the curve,
events were defined as deaths (any cause), acute
myocardial infarction in the LAD territory, or ne-
cessity of further revascularization (surgical or in the
catheterization laboratory) because of anastomotic
or graft abnormalities.
No patient had a perioperative or late myocardial
infarction in the target area. Thus LAD occlusion
did not appear to produce any harmful effect, and
the anastomotic technique was effective.
Comparison between patients with single-LAD
disease and with multiple-vessel disease. In Table
IV these two groups are compared according to
preoperative and postoperative data; clinical results
are also shown. Patients with multiple-vessel disease
were older and had lower ejection fraction, previous
coronary surgery, and higher incidence of major risk
factors. Even if clinical results were worse than in
those with the single-LAD disease, the two groups
comprise different patient populations and any com-
parison has many limitations.
Discussion
Kolessov1 pioneered LAD revascularization with
the LITA on a beating heart via a left anterior
thoracotomy, describing the same technique used
today. Recently, Benetti and Ballester2 modified the
same operation, using a thoracoscope for LITA
harvesting. Unlike them, others4, 5 harvested the
LITA under direct vision. The procedure gained
popularity; however, even though many problems
are solved, many concerns still exist on different
surgical aspects. Partial or total LITA harvesting is
one of them. Because, from the technical point of
view, we do not need the total length of the LITA to
reach the LAD, the possibility of flow competition
with the LAD territory caused by the persistence of
undivided LITA branches, has to be explored. The
LITA, like all muscular arteries, has a mainly sys-
tolic flow, with a small percentage of diastolic flow
(ratio diastolic/systolic flow , 0.3). When this artery
is grafted to the LAD, the flow pattern changes
abruptly because the diastolic component, LAD-
related, becomes predominant. Thus because flow in
a muscular artery is mainly systolic and in a coronary
flow is mainly diastolic, competition of flow cannot
exist, because they occur in two different hemody-
namic phases, as demonstrated by Luise and associ-
ates11 in the catheterization laboratory and by Kern
and associates.12
Revascularization of the LAD can be accom-
plished with different techniques, and the place of
the LAST operation has still to be determined.
Stenting is gaining more popularity because results
are improving compared with balloon angioplasty.17
Surgical revascularization, using median sternot-
omy, aortic crossclamping, and cardioplegia, pro-
vides optimal early and late results. In this scenario,
the role of minimally invasive coronary surgery is
still to be defined. Lacking results from the random-
ized study we designed and started in January 1997,
data from our experience with single-LAD disease
seem to compare favorably with those in the litera-
ture, when midterm results of coronary artery stent-
ing are reported.18 However, these questions will be
answered in the near future.
The LAST operation is a procedure that, in
single-LAD disease, can provide acceptable re-
sults. Even if 29 months are insufficient to define
the future of this surgical procedure, our results
suggest that the LAST operation will have a
well-defined role in the treatment of single-LAD
disease. A learning curve has to be considered.
However, with the experience developed by dif-
ferent teams and with new instruments, the pro-
cedure’s duration can be shortened and, perhaps,
eliminated. Randomized studies will give us the
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 4
Calafiore et al. 7 6 9
information we need to select the best treatment
for each patient.
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Discussion
Dr. Steven R. Gundry (Loma Linda, Calif.). Their LAD
occlusion time during the operation was 25 minutes. I
suspect that if a cardiologist were to stand here and tell us
that their angioplasty balloon occlusion time was 25
minutes for the LAD, all of us would be picketing the
American College of Cardiology to shut down this dan-
gerous procedure. However, have the authors assessed
regional contractility in the distal LAD distribution late,
that is, 1 year after the operation, to determine the effect
of this prolonged occlusion time? Also, 25 minutes of
occlusion time without consequence, as the authors re-
port, suggests to me that perhaps the operation was not
necessary at all in this distribution.
Now, the authors state that in 5.7% of cases the
operation was aborted and had to be done with cardio-
pulmonary bypass. The authors also state that 7% of the
patients required either an early or late operation or
required a late PTCA to that vessel. This is added to the
authors’ contention in the manuscript that 2.6% of the
patients were scheduled for a PTCA after the operation to
other branches, and an additional 1% of the patients
required other operations to other arterial branches later
in their course, bringing their less than successful treat-
ment to 11%, plus the 5.7% that could not be treated with
this technique. That is a 17% failure rate within the
reporting time.
The authors stated that a perfect patency rate at less
than 1 year was achieved in 88.6% of the patients. Could
the authors please contrast this to their experience in
patency rate of single LADs done on the pump during a
concurrent time period, not a previous time period as
reported in their manuscript.
At 1 year the authors report that 90% of their patients
are alive and asymptomatic with or without medical
treatment. For us to assess the efficacy of this operation,
the authors need to tell us how many patients 1 or 2 years
after surgery were requiring medical therapy as a portion
of their asymptomatic status, because the principle of
coronary revascularization is to eliminate or at least
extremely lessen medical therapy. Lastly, the authors need
to tell us, do they believe that this operation, which they
call the LAST procedure, is in fact the last operation?
Dr. Valavanur A. Subramanian (New York, N.Y.). I rise
to congratulate Professor Calafiore for presenting an
excellent and a very important paper in the area of
minimally invasive coronary artery bypass surgery. I must
acknowledge here that the regional cardiac wall mechan-
ical immobilization to create a still coronary artery target
site throughout the period of coronary artery anastomosis
in this operation is an important concept, which was
advanced by Professor Bos from the University of
Utrecht. As you can see from the results, the effect of the
regional cardiac wall immobilization has been a positive
one. In our own institution, of 118 LITA to LAD anasto-
moses during the last year, 108 patients underwent com-
plete angiography routinely 36 hours after surgery and
Doppler echocardiography flow assessment of the func-
tion of the anastomosis. Our patency rate is equal to what
Dr. Calafiore has reported, 97.2%, and the event-free
survival rate is similar. I do think that the regional cardiac
wall immobilization is an important and probably an
absolutely essential step in this operation. I think it is
analogous to the bailout stent, which eliminated the OR
rate from the balloon angioplasty with a similarly striking
effect.
Dr. Calafiore. Dr. Gundry, 25 minutes of occlusion time
in the distal LAD does not give any problem to the
myocardium. We know this from the experience with the
beating heart via median sternotomy. When the cardiol-
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ogist tries to open the proximal LAD, the balloon is open
in the proximal LAD. This is a very dangerous portion of
the LAD. We always perform our anastomosis below the
second diagonal branch, and we know that this is always
well supported with any patient. In using the transesoph-
ageal echocardiography we sometimes see reduction of
the contractility, a modest impairment generally; but this
is quickly reversed by the opening of the thoracic artery or
by the reopening of the distal LAD. We do not precon-
dition the myocardium. For this reason the time is a little
bit longer because we occlude the LAD immediately
before starting the anastomosis.
About the percentages, of course the operation is not
perfect and we learned a lot of things during our experi-
ence. For instance, the percentage of patients converted
reflects only the number of patients that are sent to us for
the MIDCAB, the patients in bad condition. The 7% for
a redo operation, or about 6% for a redo operation, as a
result of the problems in the harvesting of the thoracic
artery on the anastomosis reflects the learning curve. But,
as you can see, the 4 to 5 months event-free survival is the
worst period of this operation, and this is just the experi-
ence that we had during this time. Of course the results
more recently are by far better, and we are just studying to
see whether this operation has a future. But I think that all
of these figures will be reduced with time, as we did in the
last part of our experience.
The patency rate of the LITA to the LAD with a
median sternotomy, however, is not 100%, as we would
think. Concerning the patency rate of the LITA to the
LAD in studies that followed many patients for a maxi-
mum of 2 to 3 months, we know that we lose at least 5%
of the thoracic artery on the LAD in the immediate
postoperative period. So for this operation, I think the
results are as good as the other. But you must consider
that we did many patients with multiple vessel disease
because of a malignancy or high-risk factor. These pa-
tients will have medical treatment because they have other
vessel disease.
The operation was surely a palliative operation. For this
reason I wrote with or without medical treatment because
this is the group of patients for whom the medical
treatment is aggressive. The results in the single-vessel
disease are by far better than the results in the multiple-
vessel disease because of these problems. The patients are
older and have high-risk factors. In single-vessel disease,
the patients are younger and without risk factors.
About the LAST operation, yes, perhaps it is the last,
but for me it is just an acronym. Only the future will say
whether this is the last or just one of the other operations.
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